@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_head { this: np:hasAssertion dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_assertion; np:hasProvenance dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_provenance; np:hasPublicationInfo dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_publicationInfo; a np:Nanopublication . dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_assertion a np:Assertion . dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_provenance a np:Provenance . dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_publicationInfo a np:PublicationInfo . } dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_assertion { miriam-gene:10062 a ncit:C16612 . lld:C3825627 a ncit:C7057 . dgn-gda:DGN476fdd1ba6987bfcb43bf130d31b88c3 sio:SIO_000628 miriam-gene:10062, lld:C3825627; a sio:SIO_001123 . } dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_provenance { dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_assertion dcterms:description "[Inactivation of HNF4α in Caco-2 cells resulted in the following: (a) an increase in oxidative stress as demonstrated by the levels of malondialdehyde and conjugated dienes; (b) a reduction in secondary endogenous antioxidants (catalase, glutathione peroxidase, and heme oxygenase-1); (c) a lower protein expression of nuclear factor erythroid 2-related factor that controls the antioxidant response elements-regulated antioxidant enzymes; (d) an accentuation of cellular inflammatory activation as shown by levels of nuclear factor-κB, interleukin-6, interleukin-8, and leukotriene B4; (e) a decrease in the output of high density lipoproteins and of their anti-inflammatory and anti-oxidative components apolipoproteins (apo) A-I and A-IV; (f) a diminution in cellular lipid transport revealed by a lower cellular secretion of chylomicrons and their apoB-48 moiety; and (g) alterations in the transcription factors sterol regulatory element-binding protein 2, peroxisome proliferator-activated receptor α, and liver X receptor α and β.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:20871093; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP836044.RAPosY1v-sc4JHha6tZfTfWhICSayHQkxc76tXYzfDwzU130_publicationInfo { this: dcterms:created "2015-08-25T14:46:07+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }